In 2000, the FDA recklessly approved Mifeprex (mifepristone), chemical abortion drugs that violently end the lives of human persons in the womb. Additionally, these pills put mothers at risk of serious – even lethal – complications.

The FDA’s mission as an organization is to ensure drugs are safe and effective in preserving the lives and health of Americans. But they have flagrantly disregarded normal drug approval protocols, championing efficiency and political expediency above the health and safety of the American people they claim to protect.

Approving chemical abortion drugs violates the FDA’s legal obligation to protect the health, safety, and welfare of girls and women, not to mention the lives of preborn children. They have never studied the safety of these abortion drugs under the labeled conditions of use. Instead, they have blatantly ignored the impacts of these pills’ hormone-blocking regimen on the developing bodies of adolescent girls. Doing this disregards substantial evidence that chemical abortion drugs are four times as dangerous than surgical abortions, which are not safe either.

The FDA has eliminated necessary safeguards for pregnant girls and women who undergo this dangerous regimen.

Since they first approved the abortion pill, 5.9 million preborn children have been chemically destroyed by this pill. Additionally, there have been 36 reported maternal deaths associated with the drug mifepristone. Despite receiving over 4,000 reports of adverse events from women experiencing hemorrhage, excruciating abdominal pain, and severe life-threatening infections, they have continued to make this death cocktail more accessible.*

For women who take this approved pill, they face complications that could result in ER or urgent care visits. This pill does not heal women, it harms them.

Ingesting this pill is hazardous. The Association of Pro-Life Obstetricians and Gynecologists state that this pill poses a four-times higher risk of complication than surgical abortion.

When the FDA made the regulatory change to lift the in-person requirement enabling chemical abortion pills by mail, they weakened the risk of evaluation mitigation strategy (REMS), which required the abortion pill to be prescribed and dispensed at a healthcare setting, clinic, or hospital by a qualified medical professional.

Approving chemical abortion pill distribution is horrendous. These pills kill.

Historically, the abortion pill has only been prescribed by hospitals and clinicians (most often at abortion facilities) and under medical supervision. Having access to the abortion pill at local pharmacies is a deadly shift, not only because it makes it easier to kill preborn children, but also because women will not receive the medical oversight needed. For example, if a woman has an undiagnosed ectopic pregnancy, taking an abortion pill can be lethal.

President Trump, you have the power to change this. You can direct the FDA to pull the abortion pill from the market today and declare it an imminent hazard to public health.

We, the undersigned, demand that the FDA retract distribution of the abortion pill, reject approving new abortion drugs, and resist the effort by the abortion industry to lift REMS and allow dangerous, unsupervised do-it-yourself abortions.

We repeat: 36 women have died in association with this pill. 5.9 million preborn children have violently suffered, being slowly poisoned to death for hours from this pill.

Do not add to this death count.

You can call on the FDA to retract distribution of the abortion pill.

Do not allow them to be pressured into the very thing they exist to prevent.

Do not allow the FDA to distribute death.

If you continue distributing chemical abortion pills, you will be killing the next generation of Americans.

The blood of tiny innocent children in the womb who will violently suffer and suffocate slowly from the chemical abortion pills will haunt you.

Their blood is on your hands.

Do not distribute death. Women will die. Children will die. Because this pill kills.

*The FDA claims that “The adverse events cannot with certainty be causally attributed to mifepristone because of concurrent use of other drugs, other medical or surgical treatments, co-existing medical conditions, and information gaps about patient health status and clinical management of the patient.”